November 27, 2014 6:11 PM ET

Capital Markets

Company Overview of Easton Capital Investment Group

Executive Profile

Milena G. Adamian Ph.D.

Co-Founder, Viamedix
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 5 different industries.

See Board Relationships
----

Background

Dr. Milena G. Adamian, Ph.D., is the Co-Founder of Viamedix. Dr. Adamian has spent last 20 years on various side of the medical device development. She is a Founder and Executive Director of Life Sciences Angel Network, where she focused on the early stage investing and entrepreneurial activities in medical devices and healthcare information technology and education of entrepreneurs and investors. She was a Venture Partner of Easton Capital Partners and Easton Capital ...

Corporate Headquarters

767 Third Avenue
New York, New York 10017

United States

Phone: 212-702-0950
Fax: 212-702-0952

Board Members Memberships

There is no Board Members Memberships data available.

Education

MS
Columbia University
PhD
Russian Academy of Medical Sciences
MD
Russian Academy of Medical Sciences

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Easton Capital Investment Group, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.